Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2013-10-05 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Sanford C. Bernstein Strategic Decisions Conference
Investor Presentation Classification · 98% confidence The document text is titled "Sanford C. Bernstein's 10th Annual Pan-European Strategic Decisions Conference" and is dated October 1, 2013. It contains slides and bullet points detailing a business acquisition (HELIOS Hospital Network) and strategic rationale, synergies, and future growth plans. This format—a presentation deck used for investor communication, often at conferences—strongly suggests an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), nor is it a transcript (CT) or a formal report (AR, IR). Since the document is substantial in length (over 50,000 characters, though truncated), it is the presentation material itself, not just an announcement of one (RPA).
2013-10-05 English
Unternehmens Präsentation
Earnings Release Classification · 95% confidence The document contains high-level summaries, segment breakdowns (Fresenius Medical Care, Kabi, Helios, Vamed), historical performance data, outlooks for 2013, investment highlights, and share information. It explicitly mentions 'Successful First Half 2013 – Earnings Outlook Raised' and provides H1 2013 sales and EBIT figures. This structure is characteristic of an Earnings Release (ER), which provides initial key highlights following a reporting period, rather than the comprehensive details found in a full Interim Report (IR) or Annual Report (10-K). The document is promotional/summary in nature, fitting the ER definition better than the comprehensive IR definition. H1 2013
2013-10-02 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (1327 characters) and its primary purpose is to announce a specific regulatory metric: the 'Total Voting Rights' as of September 30, 2013, referencing Article 26a of the WpHG. This type of announcement, which reports a specific, discrete piece of regulatory information rather than a comprehensive report (like 10-K or IR) or a general meeting result (AGM-R or DVA), fits best under the general 'Regulatory Filings' category (RNS), as it is a mandatory disclosure that doesn't align perfectly with the other specific codes like DIV, SHA, or DVA. It is not a declaration of voting results (DVA), but a statement of the total number of rights outstanding.
2013-09-30 English
UniCredit & KeplerCheuvreux – 11th German Investment Conference
Investor Presentation Classification · 98% confidence The document is titled "UniCredit & KeplerCheuvreux – 11th German Investment Conference" and contains financial results (Sales, EBIT, Net Income) for H1 2013, segment breakdowns, operational updates (FDA inspections, drug shortages), strategic initiatives, and an updated financial outlook for 2013. The content is structured like a presentation given to investors or analysts, featuring slides, key figures, and forward-looking statements. This format strongly suggests an Investor Presentation (IP) or material related to an investor conference, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER) which is typically a press release. Since the document is a detailed presentation used for engaging with investors, the most appropriate classification is Investor Presentation (IP).
2013-09-26 English
Berenberg Bank & Goldman Sachs – 2nd German Corporate Conference
Investor Presentation Classification · 95% confidence The document is titled 'Berenberg Bank & Goldman Sachs – 2nd German Corporate Conference' and contains financial results tables (Sales, EBIT, Net Income) for 'Fresenius Group' and its segments, along with updates on operations, strategic initiatives, and raised financial outlooks for 2013. The content structure—including segment breakdowns, operational updates, and forward-looking guidance revisions—is characteristic of an investor presentation given at a conference, rather than a formal regulatory filing like a 10-K or a brief earnings release (ER). It is detailed enough to be an Investor Presentation (IP) or potentially a Management Discussion & Analysis (MDA) if it were part of a larger report, but the context of a 'Conference' strongly suggests an IP.
2013-09-25 English
Fresenius SE & Co. KGaA: Fresenius Helios acquires 43 hospitals from Rhon-Klinikum AG
M&A Activity Classification · 99% confidence The document is titled 'Ad-hoc' and explicitly discusses a major corporate action: the acquisition of 43 hospitals by Fresenius Helios from Rhön-Klinikum AG. It details the transaction price, expected impact on sales, EBITDA, and debt metrics. This type of material, announcing a significant corporate event like a merger or takeover bid, directly corresponds to the definition of M&A Activity (TAR). Although it is an 'Ad hoc announcement' (which might suggest RNS), the content is highly specific to a merger/takeover proposal, making TAR the most precise classification over the general RNS fallback.
2013-09-13 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.